ACOG Guideline Addresses Hepatitis in Pregnancy
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 22, 2023 -- In a clinical practice guideline issued by the American College of Obstetricians and Gynecologists and published online Aug. 17 in Obstetrics & Gynecology, recommendations are presented for hepatitis B and C virus screening in pregnancy, for management of patients with infection, and for vaccination.
Brenna L. Hughes, M.D., from the American College of Obstetricians and Gynecologists, and colleagues developed guidelines for pregnant or postpartum women and individuals who screen positive for viral hepatitis infection.
The authors recommend early universal prenatal screening for hepatitis B surface antigen (HBsAg) of all pregnant patients, regardless of history of testing or vaccination status. Triple panel screening (HBsAg, anti-HBs, and total anti-HBc) is recommended for all pregnant patients who do not have a documented negative triple screen result after age 18 years, those who did not complete vaccination, or those with ongoing risks for hepatitis B infection, regardless of vaccination status or testing history. In each pregnancy, all patients should be screened for hepatitis C virus antibodies. Prepregnancy screening for hepatitis C virus infection and treatment is recommended before pregnancy when possible. Women with hepatitis B or C virus infection should have prepregnancy counseling, including the effects of pregnancy on maternal disease and risks to the fetus and neonate. Recommended groups should undergo vaccination for hepatitis A virus, hepatitis B virus, or both during pregnancy.
"Hepatitis screening during pregnancy is an opportunity to promote a dialogue between pregnant patients and their clinicians about hepatitis transmission; ongoing and new risk factors; and, if not previously vaccinated, hepatitis B vaccination in pregnancy," Hughes said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Hep C Infection Poses Global Public Health Threat to Reproductive-Age Women
WEDNESDAY, May 15, 2024 -- Both acute hepatitis C (AHC) and hepatitis C virus (HCV)-related cirrhosis incidence were up substantially globally from 1990 to 2019 in...
Chronic Hepatitis B Virus Is Undertreated
FRIDAY, May 3, 2024 -- Underassessment and undertreatment of chronic hepatitis B virus (HBV) is seen globally, according to a study published online May 1 in the Journal of...
Higher Hepatitis C Virus Cure Rates Seen With Facilitated Telemedicine
FRIDAY, April 12, 2024 -- Significantly higher hepatitis C virus cure rates are seen for patients receiving opioid treatment program-integrated facilitated telemedicine versus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.